ADAR1 Capital Management’s Edgewise Therapeutics EWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$524K Buy
40,000
+20,000
+100% +$262K 0.08% 110
2025
Q1
$440K Buy
+20,000
New +$440K 0.08% 108
2024
Q4
Sell
-18,178
Closed -$485K 230
2024
Q3
$485K Sell
18,178
-418,430
-96% -$11.2M 0.08% 111
2024
Q2
$7.86M Buy
436,608
+255,697
+141% +$4.61M 1.48% 13
2024
Q1
$3.3M Buy
+180,911
New +$3.3M 0.75% 21